期刊
ANNALS OF ONCOLOGY
卷 34, 期 1, 页码 33-47出版社
ELSEVIER
DOI: 10.1016/j.annonc.2022.10.004
关键词
risk reduction; hereditary breast and ovarian cancer syndromes; BRCA; ESMO Clinical Practice Guideline